Economic evaluation of therapeutic drug monitoring services in renal transplant recipients treated with cyclosporine

Clinical pharmacy services and solid organ transplantation: a literature review

“…In most cases, only comments containing positive perceptions of clinical pharmacy services could be found. The study by Lee and colleagues [22] assessed the impact that clinical pharmacy services had on patient satisfaction and quality of life using a quality of life questionnaire and found that clinical pharmacists had a positive impact. Due to the use of different satisfaction assessment methodologies, a summary of the overall patient satisfaction with the services provided by clinical pharmacists was not possible.…”

“…Interventions that were performed in the included studies could be roughly grouped into the following categories: (1) general clinical pharmacy services (13, 68.5%) [9][10][11][12][13][14][15][16][17][18][19][20][21], (2) general clinical pharmacy services with a focus on therapeutic drug monitoring (TDM) (2, 10.5%) [22,23], (3) clinical pharmacy services that predominantly addressed compliance issues (2, 10.5%) [24,25] and (4) clinical pharmacy services that focused on patient education (2, 10.5%) [26,27]. The clinical pharmacists' activities that were reported in the 19 included studies are listed in Table 2.…”

Evaluation of risk factor management of patients treated on an internal nephrology ward: a pilot study

“…All these properties impair dose adjustments and tight drug-level control of immunosuppressant medications. There is evidence that clinical pharmacists can contribute to the vigilant supervision and management of kidney transplant patients [ 9 , 29 , 30 ].…”